Daniel Chevallard
2020
In 2020, Daniel Chevallard earned a total compensation of $635.3K as Chief Financial Officer, Chief Operating Officer, Secretary at Sunesis Pharmaceuticals.
Compensation breakdown
| Bonus | $50,000 |
|---|---|
| Non-Equity Incentive Plan | $215,820 |
| Salary | $359,700 |
| Other | $9,796 |
| Total | $635,316 |
Chevallard received $359.7K in salary, accounting for 57% of the total pay in 2020.
Chevallard also received $50K in bonus, $215.8K in non-equity incentive plan and $9.8K in other compensation.
Rankings
In 2020, Daniel Chevallard's compensation ranked 10,303rd out of 13,090 executives tracked by ExecPay. In other words, Chevallard earned more than 21.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,303 out of 13,090 | 21st |
Division Manufacturing | 4,413 out of 5,620 | 22nd |
Major group Chemicals And Allied Products | 1,825 out of 2,253 | 19th |
Industry group Drugs | 1,597 out of 1,953 | 18th |
Industry Pharmaceutical Preparations | 1,181 out of 1,458 | 19th |
Source: SEC filing on April 27, 2022.
Chevallard's colleagues
We found two more compensation records of executives who worked with Daniel Chevallard at Sunesis Pharmaceuticals in 2020.